Oxidative damage and histopathological changes in lung of rat chronically exposed to nicotine alone or associated to ethanol

Pathologie Biologie

Volumn 63, Issue 6, 2015, Pages 258-267

  Dhouib, H ^a   Jallouli, M ^a   Draief, M ^b   Bouraoui, S ^b   El Fazaa S ^a  

^a FACULTÉ DES SCIENCES DE TUNIS   (Tunisia)

^b MONGI SLIM HOSPITAL   (Tunisia)

Author keywords

Chronic nicotine exposure; Emphysema; Ethanol supplementation; Lung; Oxidative stress; Rats

Indexed keywords

ALCOHOL; CATALASE; FIBRIN; MALONALDEHYDE; NICOTINE; SUPEROXIDE DISMUTASE; THIOL; ANTIOXIDANT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAPILLARY LEAK SYNDROME; CAPILLARY PERMEABILITY; CONTROLLED STUDY; HISTOPATHOLOGY; LIPID PEROXIDATION; LONG TERM EXPOSURE; LUNG CONGESTION; LUNG DISEASE; LUNG EDEMA; LUNG EMPHYSEMA; LUNG FIBROSIS; LUNG HEMORRHAGE; LYMPHOCYTIC INFILTRATION; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; ANIMAL; DRUG ADMINISTRATION; DRUG EFFECTS; LUNG; METABOLISM; ORGAN SIZE; PATHOLOGY; PHYSIOLOGY; TIME FACTOR; WISTAR RAT;

ANIMALS; ANTIOXIDANTS; DRUG ADMINISTRATION SCHEDULE; ETHANOL; LIPID PEROXIDATION; LUNG; MALE; NICOTINE; ORGAN SIZE; OXIDATIVE STRESS; RATS; RATS, WISTAR; TIME FACTORS;

EID: 84949657928     PISSN: 03698114     EISSN: 17683114     Source Type: Journal    
DOI: 10.1016/j.patbio.2015.10.001     Document Type: Article

References (78)

1. Boyle P. Cancer, cigarette smoking and premature death in Europe: a review including the Recommendations of European Cancer Experts Consensus Meeting, Helsinki, October 1996. Lung Cancer 1997, 17:1-60.
2. Fagerstrom K. The epidemiology of smoking: health consequences and benefits of cessation. Drugs 2002, 62:1-9.
3. Piipari R., Savela K., Nurminen T., Hukkanen J., Raunio H., Hakkola J., et al. Expression of CYP1A1, CYP1B1 and CYP3A and polycyclic aromatic hydrocarbon-DNA adduct formation in bronchoalveolar macrophages of smokers and non-smokers. Int J Cancer 2000, 86:610-616.
4. Sekhon H., Proskocil B.J., Clark J.A., Spindel E.R. Prenatal nicotine exposure increases connective tissue expression in fetal monkey pulmonary vessels. Eur Respir J 2004, 23:906-915.
5. Schievelbein H., Balfour D.J.K. Nicotine and the tobacco smoking habit 1984, 1-15. Pergamon Press, Oxford.
6. Favaro W.J., Cagnon V.H. Morphometric and morphological features of the ventral prostate in rats submitted to chronic nicotine and alcohol treatment. Tissue Cell 2006, 38:311-323.
7. Benowitz N.L. Nicotine and coronary heart disease. Trends Cardiovasc Med 1991, 1:315-321.
8. Benowitz N.L. Pharmacological aspect of cigarette smoking and nicotine addiction. N Engl J Med 1988, 319:1318-1330.
9. Benowitz N.L., Porchet H., Sheiner L., Jacob P. Nicotine absorption and cardiovascular effects with smokeless tobacco use: comparison with cigarettes and nicotine gum. Clin Pharmacol Ther 1988, 4:23-28.
10. Dani J.A., Heinemann S. Molecular and cellular aspects of nicotine abuse. Neuron 1996, 16:905-908.
11. Shivij S.B., Camilo A., Moncada A.B., Clarkson, Salim M. Effect of nicotine on lung S-adenosylmethionine and development of Pneumocystis Pneumonia. J Biol Chem 2006, 280(15):15219-15228.
12. Jung B.H., Chung B.C., Chung S., Shim C. Different pharmacokinetics of nicotine following intravenous administration of nicotine base and nicotine hydrogen tartarate in rats. J Control Release 2001, 77:183-190.
13. Kovacic P., Cooksy A. Iminium metabolism for nicotine toxicity and addiction: oxidative stress and electron transfer. Med Hypotheses 2005, 64:104-111.
14. Suleyman H., Gumustekin K., Taysi S., Keles S., Oztasan N., Aktas O., et al. Benifical effects of Hippophae rhamnoides L. on nicotine oxidative stress in rat blood compared with vitamine E. Biol Pharm Bull 2002, 25:1133-1136.
15. Van der Vaar H., Postma D.S., Timens W. Acute effects of cigarette smoke on inflammation and oxidative stress: a review. Thorax 2004, 59:713-721.
16. Ben Ahmed H., Khlifi S., Rtibi K., El Fazaa S., Gharbi N. Indicators of oxidative stress in weanling and pubertal rats following exposure to nicotine via milk. Hum Exp Toxicol 2010, 29(6):489-496.
17. Yildiz D., Ercal N., Armstrong D.W. Nicotine enantiomers and oxidative stress. Toxicology 1998, 130:155-165.
18. Kalpana C., Menon V.P. Protective effect of curcumin on circulatory lipid peroxidation and antioxidant status during nicotine-induced toxicity. Toxicol Mech Methods 2004, 14:339-343.
19. Muthukumaran S., Sdheer A.R., Menon V.P., Nalini N. Protective effect of quercetin on nicotine induced prooxidant and antioxidant imbalance and DNA. Toxicology 2008, 243:207-215.
20. Yildiz D. Nicotine, its metabolism and an overview of its biological effects. Toxicon 2004, 43:619-632.
21. Grozio A., Catassi A., Cavalieri Z., Paleari L., Casario A., Russo P. Nicotine, lung and cancer. Anticancer Agents Med Chem 2007, 7:461-466.
22. Snyder M.J., Hsu E., Feyereisen R. Induction of cytochrome P-450 activities by nicotine in the tobacco hornworm, manduca sexta. J Chem Ecol 1993, 19:2903-2910.
23. Carpagnano G.E., Kharitonov S.A., Foschino-Barbaro M.P., Resta O., Gramiccioni E., Barnes P.J. Increased inflammatory markers in the exhaled breath condensate of cigarette smokers. Eur Respir J 2003, 21(4):589-593.
24. Hackett N.R., Heguy A., Harvey B.G., Kalpan R. Variability of antioxidant related gene expression in the airway epithelium of cigarette smokers. Am J Respir Cell Mol Bio 2003, 29(3):733-744.
25. Ogna A., Noirez L., Lazor R., Nicod L.P. Respiratory brochiolitis and respiratory brochiolitis-associated interstitial lung disease. Rev Med Suisse 2012, 21(8):2228-2232.
26. Schuller H.M., Orloff M. Tobacco-specific carcinogenic nitrosamines. Ligands for nicotinic acetylcholine receptors in human lung cancer cells. Biochem Pharmacol 1998, 55:1377-1384.
27. Heeschen C., Jang J., Weis M., Pathak A., Johnson F., Cooke J. Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nat Med 2001, 7:833-839.
28. Tsurutani J., Castillo S.S., Brognard J., Granville C.A., Zhang C., Gills J.J., et al. Tobacco components stimulate Akt-dependant proliferation and NF kappa B-dependant survival in lung cancer cells. Carcinogenesis 2005, 26:1182-1195.
29. Husain K., Scott R.B., Reddy K.S., Somani S.M. Chronic ethanol and nicotine interaction on rat tissue antioxidant defense system. Alcohol 2001, 25(2):89-97.
30. Leanderson P., Tagesson C. Cigarette smoke-induced DNA damage in cultured human lung cells: role of hydroxyl radicals on endonuclease activation. Chem Biol Interact 1992, 81:197-208.
31. Wetscher G.J., Bagchi M., Bagchi G., Perdikis G., Hinder P.R., Glaser K., et al. Free radical production in nicotine treated pancreatic tissue. Free Radic Biol Med 1995, 18:877-882.
32. Cahill A., Cunningham C., Adachi M., et al. Effects of alcohol and oxidative stress on liver pathology: the role of the mitochondrion. Alcoholism Clin Exp Res 2002, 26:907-915.
33. Zima T., Fialova L., Mestek O., et al. Oxidative stress, metabolism of ethanol and alcohol related diseases. J Biomed Sci 2001, 8:59-70.
34. Husain K., Somani S.M. Interaction of exercise training and chronic ethanol injection on testicular antioxidant system in rat. J Appl Toxicol 1998, 18:42-429.
35. Mehta M.C., Jain A.C., Billie M. Combined effects of alcohol and nicotine on cardiovascular performance in a canine model. J Cardiovasc Pharmacol 1998, 31:930-936.
36. Anthony J.C., Echeagaray-Wagner F. Epidemiologic analysis of alcohol and tobacco use. Alcohol Res Health 2000, 24:201-208.
37. Falk D.E., Yi H.Y., Hiller-Sturmhöfel S. An epidemiologic analysis of co-occurring alcohol and tobacco use and disorders: findings from the National Epidemiologic Survey on alcohol and related conditions. Alcohol Res Health 2006, 29:162-171.
38. Giles A.R. 1987. Guidelines for the use of animals in biomedical research. Thromb Haemost 2007, 58:1078-1084.
39. Zijlstra W.G., Kampen V.E. Standardization of hemoglobinometry. I. The extinction coefficient of hemiglobincyanide. Clin Chim Acta 1960, 5:9-26.
40. Yagi K. A simple fluorometric assay for lipoperoxide in blood plasma. Biochem Med 1976, 15:212-216.
41. Misra H.P., Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol 1972, 247:3170-3175.
42. Aebi H. Catalase in vitro. Methods Enzymol 1984, 105:121-126.
43. Hu M.-L. Measurement of protein thiol groups and glutathione in plasma. Methods Enzymol 1994, 233:380-385.
44. Bradford M. A rapid and sensitive for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-251.
45. Bancroft J.D., Stevens A. Theory and practice of histological techniques 1990, Churchill Livingstone, Edinburgh.
46. Pryor W.A., Stone K. Oxidants in cigarette smoke: radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite. Ann N Y Acad Sci 1993, 686:12-27.
47. Momi N., Ponnusamy M.P., Kaur S., Rachagani S., Kunigal S.S., Chellappan S., et al. Nicotine/cigarette smoke promotes metastasis of pancreatic cancer through a9 nAChR-mediated MUC4 upregulation. Oncogene 2013, 32:1384-1395.
48. Singh S., Pillai S., Chellappan S. Nicotinic acetylcholine receptor signaling in tumor growth and metastasis. J Oncol 2011, 456-743.
49. Pachauri V., Flora S.J.S. Effect of nicotine pretreatment on arsenic-induced oxidative stress in male Wistar rats. Hum Exp Toxicol 2013, 32:972-982.
50. Jaffe J.H. Drug addiction and drug abuse. Goodman and Gillman's the pharmacological basis of therapeutics 2007, 522-573. Pergamon, New York. 8th ed. A.G. Gilman, T.W. Rall, A.S. Niess, P. Taylor (Eds.).
51. El-Sokkary G.H., Cuzzocrea S., Reiter R.J. Effect of chronic nicotine administration on the rat lung and liver: beneficial role of melatonin. Toxicology 2007, 239:60-67.
52. Hughes J.R. Treatment of smoking cessation in smokers with past alcohol/drug problems. J Subst Abuse Treat 1993, 10:181-187.
53. DiFranza J.R., Guerrera M.P. Alcoholism and smoking. J Stud Alcohol 1990, 51(2):130-135.
54. Anandatheerthavarada H.K., Williams J.F., Wecker L. The chronic administration of nicotine induces cytochrome P-450 in rat brain. J Neurochem 1993, 60:1941-1944.
55. Guan Z.Z., Yu W.F., Nordberg A. Dual effects of nicotine on oxidative stress and neuroprotection in PC12 cells. Neurochem Int 2003, 43:243-249.
56. Shigenaga M.K., Trevor A.J., Castagnoli N. Metabolism-dependent covalent binding of (S)-[5-3H] nicotine to liver and lung microsomal macromolecules. Drug Metab Dispos 1988, 16:397-402.
57. Nims R.W., Lubet R.A. The CYP2B subfamily, in cytochromes P450. Metabol Toxicol Aspect 1996, 135-160.
58. Iba M.M., Fung J., Won Pak Y., Thomas P., Fisher H., Sekowski A., et al. Dose dependant up-regulation of rat pulmonary, renal and hepatic cytochrome P-450 (CYP) expression by nicotine feeding. Drug Metabol Dispos 1999, 27:977-982.
59. Iba M.M., Scholl H., Fung J., Thomas P.E., Alam J. Induction of pulmonary CYP1A1 by nicotine. Xenobiotica 1998, 28:827-843.
60. El-Sokkary G.H., Cuzzocrea S., Reiter R.J. Effect of chronic nicotine administration on the rat lung and liver: Beneficial role of melatonin. Toxicology 2007, 239:60-67.
61. Yamazaki H., Inoue K., Hashimoto M., Shimada T. Role of CYP2A6 and CYP2B6 in nicotine C-oxidation by human liver microsomes. Arch Toxicol 1999, 73:65-70.
62. Ames B.N., Shigenaga M.K., Hagen T.M. Oxidants, antioxidants, and degenerative diseases of aging. Proc Natl SCI U S A 1993, 90:7915-7922.
63. McCord J.M. Human disease, free radicals, and the oxidant/antioxidant balance. Clin Biochem 1993, 26:351-357.
64. Ribiere C., Hininger I., Rouach H., Nordmann R. Effects of chronic ethanol administration on free radical defence in rat myocardium. Biochem Pharmacol 1992, 44:1495-1500.
65. Dhouib H., Jallouli M., Draief M., EL-Fazaa S., Bouraoui S. The effect of nicotine and its interaction with ethanol on: biochemical parameters, oxidative damage and histological changes in the rat's liver. IOSR J Environ Sci Toxicol Food Technol 2014, 8(1):72-82.
66. Reinke L.A., Moore D.R., Hague C.M., McCay P.B. Metabolism of ethanol to 1-hydroxyethyl radicals in rat liver microsomes: comparative studies with three spin trapping agents. Free Radic Res 1994, 21:213-222.
67. Dianzani M.U. Lipid peroxidation in ethanol poisoning: a critical reconsideration. Alcohol 1985, 20:161-173.
68. Bachtell R.K., Ryabinin A.E. Interactive effects of nicotine and alcohol coadministration on expression of inducible transcription factors in mouse brain. Neuroscience 2001, 103(4):941-954.
69. Schoedel K., Tyndale R. Induction of nicotine-metabolizing CYP2B1 by ethanol and ethanol-metabolizing CYP2E1 by nicotine: summary and implications. Biochim Biophys Acta 2003, 1619:283-290.
70. Parola M., Pinzani M., Casini A., Dianzani M.U. Stimulation of lipid peroxidation or 4-hydroxynoneal treatment increases procollagen gene expression in human liver fat storing cels. Biochem Biophys Res Commun 1993, 194:1044-1050.
71. Tsukamato H., Rippe R., Lin M. Roles of oxidative stress in activation of puffer and Ito cells in liver fibrogenesis. J Gastroenterol Hepatol 1995, 10:50-53.
72. Ingelman-Sunderberg M., Johanson I., Albano E. Ethanol-inductible cytochrome P450IIE1: genetic polymorphism, regulation and possible role in the etiology of alcohol induced liver disease. Alcohol 1993, 10:447-452.
73. Crouse J., Grundy S.M. Effects of alcohol on plasma lipoproteins and cholesterol and triglyceride metabolism in man. J Lip Res 1984, 25:486-496.
74. Lieber C.S. Role of oxidative stress and antioxidant therapy in alcoholic and non-alcoholic liver diseases. Adv Pharmacol 1997, 38:601-628.
75. Folts J.D., Bonebrake F.C. The effects of cigarette smoke and nicotine on platelet thrombus formation in stenosed dog coronary arteries: inhibition with phentolamine. Circulation 1982, 65:465-470.
76. Watts D.T. The effect of nicotine and smoking on the secretion of epinephrine. Ann N Y Acad Sci 1960, 90:74-80.
77. Mounntcastle V.B. Medical physiology 1974, Mosby, Saint-Louis.
78. Kershbaum A., Bellett S. Cigarette smoking and blood lipids. JAMA 1964, 187:32.